The neurorehabilitation system will help improve walking and ambulation in adults with chronic stroke walking impairments. Credit: Ground Picture / Shutterstock.com.

MedRhythms has selected Curavit Clinical Research as its virtual contract research organisation (VCRO) for a trial of its neurorehabilitation system, MR-001.

The neurorehabilitation system has been designed to improve walking and ambulation in adults with chronic stroke walking impairments.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Outcomes and Health Economics of Stroke using Rhythmic Auditory Stimulation (OrcHESTRAS) trial aims to generate evidence and explore how the product can reduce financial burdens in the US healthcare system.

It intends to further characterise MR-001’s economic and clinical advantages beyond what has already been determined in a multi-centre, randomised clinical study.

Furthermore, the trial will assess patient engagement and therapeutic response durability.

Curavit will manage all aspects of MedRhythms’ hybrid decentralised clinical trial.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The aspects range from the finalisation of protocols and Institutional Review Board approvals to subject recruitment, physical site testing, monitoring of sites and patients remotely, healthcare economics and outcomes analysis.

The 12-month study intends to enrol 225 subjects by the end of this year.

MedRhythms president and co-founder Owen McCarthy said: “Curavit’s tech-enabled approach to research lets us launch quickly while delivering a premier experience for everyone involved.

“As important, the study will be open to participants nearly nationwide, thanks to Curavit’s virtual site solution, patient recruitment process and smart strategies for collecting real-world healthcare economics data.”

MR-001 is based on the Rhythmic Auditory Stimulation clinical approach that leverages the auditory-motor entrainment mechanism.

The brain’s motor and auditory systems subconsciously synchronise to an external auditory cue, such as music, during entrainment.